GlassScriptPhysician profile
Zaid Faraji
NPI 1154697613
$3,177.73
in general payments reported to CMS, 2019-2025
10 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.22 · 2020: $2,711 · 2022: $20.39 · 2023: $225 · 2024: $23.49 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $381.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $381.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $2,694.00 | 2020 | |
| Kls-Martin L.P. | $166.79 | 2023 | |
| Zimvie INC. | $132.82 | 2025 | |
| Salvin Dental Specialties, INC. | $39.22 | 2019 | |
| Philips North America LLC | $35.20 | 2019-2022 | |
| Nobel Biocare USA | $33.19 | 2019-2023 | Nobelactive |
| Envista Holdings Corporation | $23.49 | 2024 | Spark |
| Ormco Corporation | $22.00 | 2023 | Spark |
| Orapharma, A Division of Bausch Health US, LLC | $16.88 | 2020 | |
| Colgate Oral Pharmaceuticals, INC. | $14.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zaid Faraji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.